MacroGenics
MGNX
#8483
Rank
A$0.26 B
Marketcap
A$4.24
Share price
-3.25%
Change (1 day)
31.63%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2025 (TTM): A-$0.20

According to MacroGenics's latest financial reports the company's current EPS (TTM) is A-$0.07118. In 2024 the company made an earnings per share (EPS) of A-$1.52 a decrease over its 2023 EPS that were of A-$0.21.

EPS history for MacroGenics from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$0.20-87%
2024A-$1.52613.33%
2023A-$0.21-92.31%
2022A-$2.78-42.14%
2021A-$4.8036.44%
2020A-$3.52-21.84%
2019A-$4.50-24.58%
2018A-$5.96675.93%
2017A-$0.77-68.05%
2016A-$2.41168.25%
2015A-$0.90-55%
2014A-$1.993400%
2013A-$0.05694-108.68%
2012A$0.6624.49%
2011A$0.53

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.94-2,820.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$32.77-46,139.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$20.40-28,760.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$9.28-13,140.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$10.40-14,713.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$4.23-6,040.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A-$2.52 3,440.00%๐Ÿ‡บ๐Ÿ‡ธ USA